Episodes
Monday Feb 28, 2022
Quoin Pharmaceuticals Mission is to Deliver Hope to Those Who Need it Most
Monday Feb 28, 2022
Monday Feb 28, 2022
Rare diseases are only rare if you don't live with one
Through the Prism takes a closer look at Rare Disease Day, a day that recognizes the challenges faced by the 300 million people around the world who live with a rare disease. In this episode, Quoin Pharmaceuticals (NASDAQ: QNRX) co-founders Michael Myers and Denise Carter, call in to discuss their mission to develop and deliver unique solutions for rare diseases.
Tuesday Oct 05, 2021
Tuesday Oct 05, 2021
Soligenix’s work in public health has become even more critical and timely as America moves through the Covid-19 pandemic, contemplating life where Covid might always be present, as well as preparing for the next potential pandemic. The company’s Covid vaccine candidate has demonstrated efficacy and broad neutralizing antibody responses against the original strain as well as Beta, Gamma and Delta variants of the virus in non-human primates.
Sunday Sep 12, 2021
Pandemic Preparedness: Are We Ready for the Next Big One?
Sunday Sep 12, 2021
Sunday Sep 12, 2021
COVID-19 taught us the importance of preparing for global health threats. On this episode, we highlight how late stage biopharmaceutical company Soligenix (NASDAQ: SNGX) is developing tools to prepare for the next potential pandemic.